Area of research
Epidemiology · Immunology
Research interest
Research focused on Septic shock and Biomarker, with related work in Intensive care medicine, ARDS, Subclass. Notable publications include 'Developing a Clinically Feasible Personalized Medicine Approach to Pediatric Septic Shock', 'Exuberant fibroblast activity compromises lung function via ADAMTS4', and 'Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype'.
Exuberant fibroblast activity compromises lung function via ADAMTS4
RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness
Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant <i>Staphylococcus aureus</i> Coinfection in Children With Influenza-related Critical Illness
Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype
Combining Prognostic and Predictive Enrichment Strategies to Identify Children With Septic Shock Responsive to Corticosteroids*
A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury
Developing a Clinically Feasible Personalized Medicine Approach to Pediatric Septic Shock
Multicenter Randomized Controlled Trial of Inhaled Nitric Oxide for Pediatric Acute Respiratory Distress Syndrome
Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children